Evidence map›Paper›PMID 42455450›Full record

ArticleJournal of prevention (2022)2026

Why Prevention Needs More Than Individual Empowerment: Reclaiming Environmental Prevention.

Gregor Burkhart, Maximilian von Heyden

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of prevention (2022), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gregor BurkhartEUSPR, Geneva, Switzerland. gregorbu@gmail.com.ORCID http://orcid.org/0000-0002-5180-8590
Maximilian von HeydenFinder Academy, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contemporary prevention discourse increasingly defines its mission as "empowering individuals" - building resilience, skills and assertiveness so that people can resist substance use, bullying, abuse, gambling, violence and gender-based harms. Such individual-level (i-frame) interventions can be effective, and several rest on a solid evidence base. Drawing on Chater and Loewenstein's i-frame/s-frame distinction and on classical public-health scholarship from Rose, McKinlay, Marmot and Marteau, this paper argues that the field has drifted into a near-monopoly of the i-frame and sidelined the environmental, regulatory and commercial determinants that public health itself rates as most effective. We trace the trend through six domains (substance use, bullying, child sexual abuse, youth violence, gender-based prevention and gambling) and through a telling institutional silence about it. We argue that this drift is reinforced by a market-fundamentalist "Illegitimacy Thesis" that frames any structural measure as paternalism, and by commercial and political actors with a direct interest in keeping policy on the individual side of the scale. Even high-quality developmental programmes hit a ceiling when the surrounding environment and its neurobehavioural consequences continues to push in the opposite direction. We read the two frames as complementary rather than rival; the problem we diagnose is their current imbalance, not the use of individual-level methods as such. We propose three correctives: restoring environmental language to foundational declarations, treating prevention systems as social ecologies rather than delivery pipelines for individual-level programmes, and naming and acting on the vested interests that shape the frame. The lesson of nineteenth-century cholera - fix the water, do not teach every household to boil it - is the lesson prevention has yet to fully relearn.

Indexed as

Commercial determinants of healthEnvironmental preventionEquityI-frameS-frameSubstance use preventionViolence prevention

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.